Endpoints News 2026-02-23 A federal experiment opens up a new market for digital health — if it works
Endpoints News 2026-02-23 Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Endpoints News 2026-02-22 MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win
Endpoints News 2026-02-21 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more